Literature DB >> 8547552

Effects of dexmedetomidine on coronary hemodynamics and myocardial oxygen balance.

J Jalonen1, L Halkola, K Kuttila, J Perttilä, A Rajalin, T Savunen, M Scheinin, M Valtonen.   

Abstract

OBJECTIVE: alpha 2-adrenergic agonists decrease central sympathetic outflow and maintain normal transmural myocardial blood flow distribution, but intravenous bolus doses of these agents can also induce excessive coronary vasoconstriction and myocardial ischemia. The hypothesis of the present study was that a rapid intravenous bolus of dexmedetomidine, a specific alpha 2-adrenergic agonist, will cause coronary vasoconstriction and accompanying myocardial ischemia in young pigs.
DESIGN: Prospective, controlled study on experimental animals.
SETTING: Animal laboratory of a university cardiorespiratory research center. PARTICIPANTS: Twelve domestic 8-week-old open-chest pigs, anesthetized with high-dose fentanyl. Another six pigs served as controls.
INTERVENTIONS: Sequential intravenous dexmedetomidine boluses of 3, 10, and 30 mg/kg were administered, and responses were measured during peak changes (2 minutes after injection) and during recovery after each dose.
MEASUREMENTS AND MAIN RESULTS: Left anterior descending coronary artery blood flow, calculated regional coronary vascular resistance, myocardial extraction of oxygen and lactate, plasma catecholamine levels, and conventional central hemodynamic parameters were measured. The two higher doses of dexmedetomidine induced 21% and 29% immediate increases in left anterior descending coronary artery blood flow. At the same time mean systemic blood pressure and pulmonary capillary wedge pressure increased, and calculated regional coronary vascular resistance increased. Myocardial extraction of oxygen and lactate remained unchanged.
CONCLUSIONS: Large intravenous doses of dexmedetomidine caused moderate regional coronary vasoconstriction without metabolic signs of myocardial ischemia in young domestic pigs at the same time as a marked vasoconstrictive response in the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8547552     DOI: 10.1016/s1053-0770(05)80134-x

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  8 in total

1.  Safety and efficacy of dexmedetomidine in children with heart failure.

Authors:  Francis Lam; Chase Ransom; Jeffrey M Gossett; Aaron Kelkhoff; Paul M Seib; Michael L Schmitz; Janet C Bryant; Elizabeth A Frazier; Punkaj Gupta
Journal:  Pediatr Cardiol       Date:  2012-10-09       Impact factor: 1.655

Review 2.  Dexmedetomidine: applications for the pediatric patient with congenital heart disease.

Authors:  Joseph D Tobias; Punkaj Gupta; Aymen Naguib; Andrew R Yates
Journal:  Pediatr Cardiol       Date:  2011-09-10       Impact factor: 1.655

3.  Coronary Spasm During Postoperative Sedation With Dexmedetomidine.

Authors:  Yu Sato; Tomoka Matsumura; Yushi Abe; Chihiro Kutsumizu; Shigeru Maeda
Journal:  Anesth Prog       Date:  2022-09-01

4.  c-Jun NH₂-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle.

Authors:  Seong-Ho Ok; Young Seok Jeong; Jae-Gak Kim; Seung-Min Lee; Hui-Jin Sung; Hye Jung Kim; Ki Churl Chang; Seong-Chun Kwon; Ju-Tae Sohn
Journal:  Yonsei Med J       Date:  2011-05       Impact factor: 2.759

5.  Dexmedetomidine-Induced Contraction in the Isolated Endothelium-Denuded Rat Aorta Involves PKC-δ-mediated JNK Phosphorylation.

Authors:  Jongsun Yu; Seong-Ho Ok; Won Ho Kim; Hyunhoo Cho; Jungchul Park; Il-Woo Shin; Heon Keun Lee; Young-Kyun Chung; Mun-Jeoung Choi; Seong-Chun Kwon; Ju-Tae Sohn
Journal:  Int J Med Sci       Date:  2015-09-04       Impact factor: 3.738

6.  Dexmedetomidine: present and future directions.

Authors:  Seongheon Lee
Journal:  Korean J Anesthesiol       Date:  2019-06-21

7.  Dexmedetomidine inhibits vasoconstriction via activation of endothelial nitric oxide synthase.

Authors:  Lidan Nong; Jue Ma; Guangyan Zhang; Chunyu Deng; Songsong Mao; Haifeng Li; Jianxiu Cui
Journal:  Korean J Physiol Pharmacol       Date:  2016-08-26       Impact factor: 2.016

8.  Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes.

Authors:  Ke Peng; Yun Qiu; Jian Li; Zhao-Cai Zhang; Fu-Hai Ji
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.